Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease

Published:2015-09-02 Issue:7 Volume:42 Page:939-940
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Paul S.¹,Roblin X.²,Peyrin-Biroulet L.³

Affiliation:

1. Laboratoire d'Immunologie et d'Immunomonitoring; CIC INSERM 1408 Vaccinologie; GIMAP EA3064; CHU de Saint-Etienne; Saint-Etienne France

2. Service de Gastrologie-Entérologie-Hépatologie; CHU de Saint-Etienne; Saint-Etienne France

3. Inserm U954 and Department of Gastroenterology; Nancy University Hospital; Henri Poincaré University; Vandoeuvre-lès-Nancy France

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13335/fullpdf

Reference3 articles.

1. Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy;Gisbert;Aliment Pharmacol Ther,2015

2. Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal;Ben-Horin;Aliment Pharmacol Ther,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05

2. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis;Gastroenterología y Hepatología (English Edition);2024-05

3. De-escalation of Biologic Treatment in Inflammatory Bowel Disease: A Comprehensive Review;Journal of Crohn's and Colitis;2023-11-01

4. Immunogenicity of biologics used in the treatment of inflammatory bowel disease;Human Antibodies;2021-11-22

5. Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India;Indian Journal of Gastroenterology;2020-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3